Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration
There are over 70 markers on the organic acids test including vitamins and antioxidants, oxidative stress, energy production, detoxification, neurotransmitter levels, oxalates, and intestinal yeast and bacteria
You can send us your product specifications and requirements, and we will produce the products according to your requirements
By modulating the inflammatory phase of healing, GHK-Cu prevents the prolonged inflammation that impedes repair and encourages resolution toward regeneration